These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34395043)

  • 1. Severe Diabetic Ketoacidosis in a Child with Type-1 Diabetes, Asthma, and COVID-19.
    Vasconez WA; Bustamante Escobar CL; Agarwal N; Solano JP; Sanchez JE
    J Pediatr Intensive Care; 2021 Sep; 10(3):232-234. PubMed ID: 34395043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic Ketoacidosis and COVID-19: A Retrospective Observational Study.
    Nagdev G; Chavan G; Gadkari C; Sahu G
    Cureus; 2022 Oct; 14(10):e30895. PubMed ID: 36465737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic ketoacidosis precipitated by COVID-19: A report of two cases and review of literature.
    Reddy PK; Kuchay MS; Mehta Y; Mishra SK
    Diabetes Metab Syndr; 2020; 14(5):1459-1462. PubMed ID: 32771918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Perfect Storm: Rapid Progression of Diabetic Ketoacidosis in Pediatric Diabetes in the Setting of COVID-19.
    Modarelli R; Balikcioglu PG; Hendrix G; DeRusso M; Ozment C
    AACE Clin Case Rep; 2021; 7(6):357-359. PubMed ID: 34104714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: an observational cohort study.
    Dżygało K; Nowaczyk J; Szwilling A; Kowalska A
    Pediatr Endocrinol Diabetes Metab; 2020; 26(4):167-175. PubMed ID: 33554490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Insulin Infusion Requirements in COVID-19-Infected Patients With Diabetic Ketoacidosis.
    Farzadfar D; Gordon CA; Falsetta KP; Calder T; Tsegaye A; Kohn N; Schulman-Rosenbaum R
    Endocr Pract; 2022 Aug; 28(8):787-794. PubMed ID: 35623591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic ketoacidosis incidence among children with new-onset type 1 diabetes in Poland and its association with COVID-19 outbreak-Two-year cross-sectional national observation by PolPeDiab Study Group.
    Pietrzak I; Michalak A; Seget S; Bednarska M; Beń-Skowronek I; Bossowski A; Chobot A; Dżygało K; Głowińska-Olszewska B; Górnicka M; Horodnicka-Józwa A; Jakubek-Kipa K; Jarosz-Chobot P; Marcinkiewicz K; Mazur A; Myśliwiec M; Nazim J; Niechciał E; Noczyńska A; Rusak E; Seifert M; Skotarczyk-Kowalska E; Skowronek A; Szypowska A; Wais P; Walczak M; Wołoszyn-Durkiewicz A; Wysocka-Mincewicz M; Zubkiewicz-Kucharska A; Szadkowska A
    Pediatr Diabetes; 2022 Nov; 23(7):944-955. PubMed ID: 35700323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aversion to Hospital Admission Due to Fear of COVID Infection Leading to Fatality From Diabetic Ketoacidosis.
    Mohammad Ashraf H; Sunderajan T; Pierre L; Kondamudi N; Adeyinka A
    Cureus; 2021 Dec; 13(12):e20251. PubMed ID: 35018256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Severe Cases and New-Onset Type 1 Diabetes Among Children Presenting With Diabetic Ketoacidosis During First Year of COVID-19 Pandemic in Turkey.
    Kiral E; Kirel B; Havan M; Keskin M; Karaoglan M; Yildirim A; Kangin M; Talay MN; Urun T; Altug U; Kesici S; Tufan E; Kacmaz E; Bozan G; Azapagasi E; Uysal Yazici M; Ozturk Z; Yesilbas O; Karaguzel G; Kaya G; Barlas U; Duyu M; Boyraz M; Sevketoglu E; Akcay N; Hancili S; Guven A; Dursun O; Ulgen Tekerek N; Ozcifci G; Yazici P; Turanli E; Kendirli T; Kahveci F; Yetimakman AF; Citak A; Şik G; Bingol I; Aygun F; Durak C; Yilmaz R; Bugrul F; Sari Y; Tekguç H; Albayrak H; Yener N; Agin H; Soydan E; Yildizdas D; Dilek SO; Yalindag N; Incekoy-Girgin F; Alacakir N; Tutunculer F; Arslanaoglu MO; Aydin C; Bilgin M; Simsek E; Dinleyici EC
    Front Pediatr; 2022; 10():926013. PubMed ID: 35844756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of COVID-19 Pandemic Lockdown on the Incidence of New-Onset Type 1 Diabetes and Ketoacidosis Among Saudi Children.
    Alaqeel A; Aljuraibah F; Alsuhaibani M; Huneif M; Alsaheel A; Dubayee MA; Alsaedi A; Bakkar A; Alnahari A; Taha A; Alharbi K; Alanazi Y; Almadhi S; Khalifah RA
    Front Endocrinol (Lausanne); 2021; 12():669302. PubMed ID: 33868185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of diabetic ketoacidosis during COVID-19 pandemic: a meta-analysis of 124,597 children with diabetes.
    Elgenidy A; Awad AK; Saad K; Atef M; El-Leithy HH; Obiedallah AA; Hammad EM; Ahmad FA; Ali AM; Dailah HG; Elhoufey A; Taha SF
    Pediatr Res; 2023 Apr; 93(5):1149-1160. PubMed ID: 35953513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in the Number of Pediatric New-Onset Diabetes and Diabetic Ketoacidosis Cases During the COVID-19 Pandemic.
    Chambers MA; Mecham C; Arreola EV; Sinha M
    Endocr Pract; 2022 May; 28(5):479-485. PubMed ID: 35189332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Presenting With Diabetic Ketoacidosis: A Case Series.
    Gorthi RS; Kamel G; Dhindsa S; Nayak RP
    AACE Clin Case Rep; 2021; 7(1):6-9. PubMed ID: 33521253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery From Acute Kidney Injury With Diabetic Ketoacidosis Following SARS-CoV-2 Infection: A Case Report and Literature Review.
    Xu C; Zia U
    Cureus; 2020 Nov; 12(11):e11702. PubMed ID: 33391935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of septic shock in two pediatric patients with severe diabetic ketoacidosis using invasive hemodynamic monitoring: a case report.
    Saeed A; Ziyaee F
    BMC Endocr Disord; 2023 Mar; 23(1):65. PubMed ID: 36941647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of the SARS-CoV-2 Pandemic on Presentation with Diabetic Ketoacidosis in Children with New Onset Type 1 Diabetes Mellitus.
    Jalilova A; Ata A; Demir G; Işıklar H; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):264-267. PubMed ID: 36987789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors.
    Vitale RJ; Valtis YK; McDonnell ME; Palermo NE; Fisher NDL
    AACE Clin Case Rep; 2021; 7(1):10-13. PubMed ID: 33521255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual insulin resistance causes: how frequently type 2 diabetes mellitus and COVID-19 infection caused diabetic ketoacidosis? a case report.
    Bereda G
    Ann Med Surg (Lond); 2023 Apr; 85(4):1096-1099. PubMed ID: 37113916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Incidence of Pediatric Diabetic Ketoacidosis After COVID-19: A Two-Center Retrospective Study in Korea.
    Han MJ; Heo JH
    Diabetes Metab Syndr Obes; 2021; 14():783-790. PubMed ID: 33654417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic Characteristics of Children with Diabetic Ketoacidosis Treated in a Pediatric Intensive Care Unit in a 10-Year-Period: Single Centre Experience in Croatia.
    Lah Tomulić K; Matko L; Verbić A; Milardović A; Severinski S; Kolić I; Baraba Dekanić K; Šerifi S; Butorac Ahel I
    Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.